The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial
Mark Packer Packer Research Associates, Boulder, CO, USACorrespondence: Mark Packer, Packer Research Associates, 1400 Bluebell Ave, Boulder, CO, 80302, USA, Tel +1 541 915 – 0291, Email mark@markpackerconsulting.comPurpose: To evaluate the safety and effectiveness of collamer posterior chamber phaki...
Main Author: | Packer M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/the-evo-icl-for-moderate-myopia-results-from-the-us-fda-clinical-trial-peer-reviewed-fulltext-article-OPTH |
Similar Items
-
Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial
by: Packer M
Published: (2022-05-01) -
Performance and Safety of the Extended Depth of Focus Implantable Collamer® Lens (EDOF ICL) in Phakic Subjects with Presbyopia
by: Packer M, et al.
Published: (2020-09-01) -
Performance and Safety of the Extended Depth of Focus Implantable Collamer® Lens (EDOF ICL) in Phakic Subjects with Presbyopia [Corrigendum]
by: Packer M, et al.
Published: (2020-10-01) -
Visual Acuity Improvement in Low, Moderate and High Myopia After Posterior-Chamber Phakic Implantable Collamer Lens Surgery in a Large Patient Cohort
by: Zaldivar R, et al.
Published: (2023-04-01) -
Toric implantable phakic contact lens versus bioptics for the correction of moderate to high myopia and astigmatism
by: Amr A Elbakry, et al.
Published: (2023-01-01)